New drug BBD-1 shows promise for painful skin and kidney disease
NCT ID NCT07595367
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, BBD-1, against standard steroids for IgA vasculitis, a disease that causes purple spots on the skin, joint pain, and can damage the kidneys. The trial will enroll 30 adults with confirmed IgA vasculitis. The goal is to see if BBD-1 can clear skin spots, relieve joint pain, and protect kidney function better than current treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BBD-1 multi-target immune enhancement targeting agent
What this could lead to
If successful, BBD-1 could offer a new treatment option for IgA vasculitis that works faster and with fewer side effects than current steroids.
What could go wrong
This is a small Phase 2 trial with only 30 people, so results may not apply to everyone. Long-term safety and effectiveness are not yet known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC REACTION (IGA) VASCULITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Forest ecological agriculture
Baltimore, Maryland, 21287, United States
-
Forest ecological agriculture
Liaocheng, Shandong, 252000, China